Best Life Sciences Platforms and Tools Companies in Baden Wurttemberg, Germany
The 62 best Life Sciences Platforms and Tools companies in Baden Wurttemberg, Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Subitec.
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Baden Wurttemberg
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 4HF Biotec Provider of data analytics and bioinformatics for cancer research | — | — | — | Heiner Fiebig Md Prof Em CEO and Founder | — | — | — | — |
| 2 | Ad-O-Lytics Geneti-chemical platform for systemic administration of oncolytic viruses via the bloodstream | — | — | — | Stefan Kochanek Co-Founder & Developer | — | — | — | — |
| 3 | Apara Bioscience Synthesis of oligonucleotides and peptides | — | — | — | Ulrich Birsner CEO & MD | — | — | — | — |
| 4 | ATOLL-bio Developer of chromatography columns for pharmaceutical companies | — | — | 11 | Juergen Friedle CEO | Cart FunctionalityMicrosoft ASP.NETAMP+2 | Top 1M | — | — |
| 5 | BF- BIO labs Nucleic acid and protein microarray printing services | — | — | — | Patric Zeltz CEO | — | — | — | — |
| 6 | BINDER Manufacturer of simulation chambers for the scientific and industrial laboratory | — | — | 13 | Peter Binder Founder | TYPO3 CMSApple iCloud MailMicrosoft 365+20 | Top 5M | 247 patents Sealing profiles and modular housings for HVAC and laboratory equipment | 1 expansion |
| 7 | BioFluidix Low volume liquid handling based on microfluidic technology | — | — | 20 | Andreas Ernst CEO | — | — | 15 patents Precision micro‑dosing and nanoliter droplet dispensing devices for lab‑on‑chip fluids | 1 launch |
| 8 | Biokryo Cryopreservation services for biological samples | — | — | — | Vincent von Walcke-Wulffen CEO | — | — | 3 patents Cryogenic cooling and freezing systems for preserving biological and medical specimens | — |
Top 12 Life Sciences Platforms and Tools companies in Baden Wurttemberg
#1
Funding Raised · Reutlingen, Baden Wurttemberg · founded 2009$1.6Mraised▾
Cellendes is a life science company developing solutions for the design of materials that mimic cell environments in 3-D cell culture. The company is commercializing an integrated system for the generation of biomimetic hydrogels for use in 3D cell culture, called 3-D Life. The 3-D Life system consists of two polymers that form a hydrogel by covalent crosslinking at ambient temperature. The chemical reaction is non-toxic to cells and occurs rapidly, preventing cell settlement before the gel is formed. The company manufactures pre-configured, fast-gelling and slow-gelling hydrogels, hydrogel components like cross-linkers, and thiol-reactive polymers, cell adhesion peptides, and other reagents.
- Oct 2022Grant (prize money)$407.2K
- Jul 2019Grant (prize money)$531.2K
- Jan 2016Grant (prize money)$639.9K
#2
Acquired · Reutlingen, Baden Wurttemberg · founded 1996 · 68 employees$2.6Mraised▾
Multi Channel Systems is a part of Havard Bioscience and engages in developing tools and systems for electrophysiology. The product portfolio of the company In - Vitro MEA systems, In vivo ME systems, Patch server, Xenopus Oocyte, Stimulus generators, software, microelectrode array, HEKA, Warner Instruments, Senapex, Imaging systems, and other accesories.
- Jun 2021Grant (prize money)$703.9K
- Oct 2020Grant (prize money)—
- Apr 2020Grant (prize money)$385.6K
- Jan 2020Grant (prize money)$251.1K
#3
Funding Raised · Eggenstein Leopoldshafen, Baden Wurttemberg · founded 2018 · 8 employees$2Mraised▾
Aquarray is the provider of droplet microarray technology for clinical application. The droplet microarray is the patented technology for cell cultivation, ultra high throughput screening (uHTS) and biochemical assay platforms. In cell screening, it requires a minimum number of cells that is 1-100 cells.
- Jan 2022Grant (prize money)$55.7K
- Feb 2020Grant (prize money)$1.9M
#4
Funding Raised · Eggenstein Leopoldshafen, Baden Wurttemberg · founded 2012$30.5Kraised▾
Developer of gene transfer technology and transfection reagents. The company is focusing on the development of transfection reagents for siRNA (ScreenFect siRNA), mRNA (ScreenFect mRNA), and fluorescent reagents (ScreenFect Green and ScreenFect Red), as well as a multipurpose reagent (ScreenFect A).
- Jan 2024Grant (prize money)$30.5K
#5
Acquired · Freiburg im Breisgau, Baden Wurttemberg · founded 2014 · 71 employees$4.6Mraised▾
Cytena has developed a device called cy-Clone to separate single cells. Single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research. The cy-Clone is supported by an automated imaging process to encapsulate cells in droplets, which are delivered to any type of substrate.
- Mar 2019Series A$3.4M
- Apr 2015Seed$1.2M
#6
Series A · Stuttgart, Baden Wurttemberg · founded 2000 · 9 employees$6.3Mraised▾
Subitec was founded in 2000 as a spin-off of the Fraunhofer Institute for Interfacial and Biotechnology (IGB). Started actual operations in 2007. It has developed technology for cultivation of micro-algae. The technology involves use of special photobioreactor called Flat Panel Airlift (FPA) reactor which it claims offers more cellular density compared to open pond cultivation.
- Jul 2012Series A$5.5M
- Jun 2007Seed$824K
#7
Series A · Tubingen, Baden Wurttemberg · founded 2010 · 11 employees$4.3Mraised▾
Biametrics develops and markets label-free analytical system solutions for life science applications. The patented label-free biosensor technology includes innovative detection, surface chemistry and assay development for the time-resolved analysis of any kind of biomolecular interaction. Its label free 1lambda technology is available in the: b-screen device for microarray applications and b-portable device for smart biomolecular interaction analysis at the point-of-need.
- Sep 2015Series A$3.5M
- Feb 2014Grant (prize money)$275.9K
- Sep 2010Seed$816.6K
#8
Acquired · Konstanz, Baden Wurttemberg · founded 2014 · 10 employees$638.9Kraised▾
Provider of engineered DNA polymerases for molecular biology applications. The company is developing new generations of DNA polymerases for applications such as pathogen detection, DNA and RNA diagnostics, forensics, and others.
- Apr 2020Grant (prize money)$316.5K
- Jan 2020Grant (prize money)$322.4K
#9
Seed · Reutlingen, Baden Wurttemberg · founded 2018$80Kraised▾
MR Shim is developing magnetic resonance imaging and spectroscopy. Its products offering includes B0 shimming software, FIDGet is the high-performance spectral processing, and shim amplifiers are the High-performance digital amplifiers.
- Jun 2022Grant (prize money)$80K
- 2019Seed—
#10
Funding Raised · Ortenberg, Baden Wurttemberg · founded 1989 · 24 employees$1.1Mraised▾
BMG Labtech develops, manufactures, and markets a wide range of multi-mode microplate readers and associated accessories for life sciences applications and high-throughput screening. Its product line includes multi-mode microplate readers that combine filters, spectrometer, and - in the CLARIOstar - innovative LVF Monochromators, Absorbance microplate readers, Fluorescence microplate readers, Luminescence microplate readers, and Nephelometry microplate readers.
- Nov 2016Grant (prize money)$544.5K
- Jan 2016Grant (prize money)$534.8K
#11
Funding Raised · Merzhausen, Baden Wurttemberg · founded 2001$966.5Kraised▾
Provider of a technology platform for gene synthesis. The company specializes in multi-gene and multi-protein expression products and customized services involving gene synthesis, optimization and expression systems, and synthetic bioinformatics to enable complex combinatorial gene and gene-cluster designs and multi-gene expression strategies. The company offers its services to pharmaceutical companies, molecular diagnostics, and bioengineering companies.
- Apr 2015Grant (prize money)$966.5K
#12
Acquired · Baden Baden, Baden Wurttemberg · founded 1998 · 289 employees$700.1Kraised▾
Diarect specializes in the development and production of recombinant and native antigens that are used in the development of immunoassays. The company manufactures a host of allergens (found in food, grasses and trees), a large collection of autoimmune disease antigens (including, SARD, Mixed Connective Tissue Disease, SLE, Sjøgrens Syndrome, Systemic Sclerosis / CREST Syndrome, Polymyositis / Dermatomyositis, Autoimmune Thyroid Diseases, Celiac Disease, Autoimmune Hepatitis, Primary Biliary Cirrhosis, ANCA-Associated Diseases, Antiphospholipid Syndrome/ Thromboembolic Syndrome, Anti-GBM Disease, Diabetes Mellitus, Pernicious Anemia, Crohn’s Disease), and infectious disease antigens (including Anaplasmosis, Babesiosis, Borreliosis / Lyme Disease / Relapsing Fever, Candidiasis, Erythema infectiosum, Scarlet Fever, Yersiniosis). The company is also the European distributor of SurModics' protein stabilization reagents and blockers and BioFX substrates.
- Jul 2016Grant (prize money)$700.1K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics is moving in Germany
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 2,605 Germany-affiliated papers.
- Heidelberg University245
- German Cancer Research Center123
- Charité - Universitätsmedizin Berlin95
- Goethe University Frankfurt94
- Ludwig-Maximilians-Universität München91
- Genome13→106
- Gene16→108
- Transcriptome6→61
- Epigenetics2→40
- Context (archaeology)1→33
- Disease1→62
- Gene3→49
- Immune system1→41
- Transcriptome4→37
- Biomarker1→29
- Disease2→41
- Immune system1→29
- Gene4→24
- Genome2→20
- Cancer1→14
Where bioinformatics is researched across Germany
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.